摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,2S,3R,5S)-3-Benzyloxy-2-benzyloxymethyl-6-oxa-bicyclo[3.1.0]hexane | 873298-16-9

中文名称
——
中文别名
——
英文名称
(1R,2S,3R,5S)-3-Benzyloxy-2-benzyloxymethyl-6-oxa-bicyclo[3.1.0]hexane
英文别名
(1R,2S,3R,5S)-3-(Benzyloxy)-2-[(benzyloxy)methyl]-6-oxabicyclo[3.1.0]hexane;(1R,2S,3R,5S)-3-phenylmethoxy-2-(phenylmethoxymethyl)-6-oxabicyclo[3.1.0]hexane
(1R,2S,3R,5S)-3-Benzyloxy-2-benzyloxymethyl-6-oxa-bicyclo[3.1.0]hexane化学式
CAS
873298-16-9
化学式
C20H22O3
mdl
——
分子量
310.393
InChiKey
YPDRJNPIGFCETD-ZGXWSNOMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    427.9±40.0 °C(Predicted)
  • 密度:
    1.17±0.1 g/cm3(Predicted)
  • 溶解度:
    可溶于二氯甲烷、乙醚、乙酸乙酯

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    23
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    31
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (1R,2S,3R,5S)-3-Benzyloxy-2-benzyloxymethyl-6-oxa-bicyclo[3.1.0]hexanesodium hydroxide1,8-二氮杂双环[5.4.0]十一碳-7-烯三苯基膦偶氮二甲酸二乙酯 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 生成 (1'R,2'S,3'R,4'R)-1-(4-benzyloxy-3-benzyloxymethyl-2-hydroxycyclopentyl)uracil
    参考文献:
    名称:
    Synthesis and hybridization properties ofl-oligodeoxynucleotide analogues fixed in a low anti glycosyl conformation
    摘要:
    我们合成了核苷类似物的 L 型对映体(cU 和 cA),其糖基键以低反构象(ap 糖基构象,χ ≈ 180°)固定,并将其加入寡核苷酸中,评估其与天然 DNA 和 RNA 序列的杂交能力。虽然将修饰的核苷掺入寡核苷酸中会降低与未修饰的互补 DNA 序列的杂交能力,但完全取代的 12 聚体(cU12 和 cA12)仍能保持与未修饰的互补 DNA 12 聚体的杂交能力,而不管它们的非天然 L 手性如何。cU12 与 rA12 形成的双链比相应的天然 12 聚体(dT12)更稳定,而 cA12 则不能与 rU12 杂交。基于 cU12-rA12 的模型结构,我们对这些实验结果进行了讨论。
    DOI:
    10.1039/b312276j
  • 作为产物:
    参考文献:
    名称:
    BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro
    摘要:
    BMS-200475, a novel carbocyclic analog of 2'-deoxyguanosine, is a potent inhibitor of hepatitis B virus in vitro (ED(50)=3 nM) with relatively low cytotoxicity (CC50=21-120 mu M). A practical 10-step asymmetric synthesis was developed affording BMS-200475 in 18% overall chemical yield and >99% optical purity. The enantiomer of EMS-200475 as well as the adenine, thymine, and iodouracil analogs are much less active. (C) 1997, Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(96)00594-x
点击查看最新优质反应信息

文献信息

  • Design and Racemic Synthesis of Conformationally Restricted Carbocyclic Pyrimidine Nucleoside Analogs Based on the Structure of the L-Nucleoside Residue in Heterochiral DNA.
    作者:Hidehito URATA、Hidetaka MIYAGOSHI、Hitoshi KAKUYA、Hideki TOKUMOTO、Takuya KAWAHATA、Toru OTAKE、Masao AKAGI
    DOI:10.1248/cpb.46.458
    日期:——
    Carbocyclic pyrimidine nucleoside analogs which have restricted glycosidic conformation at chi approximately 180 degrees were designed, based on the conformational features of the L-nucleotide residue in heterochiral DNA, and synthesized. The synthesis of (+/-)-carbocyclic 6,6'-O-cyclo-2'-deoxyuridine was achieved via bromination and subsequent intramolecular cyclization of carbocyclic 6'beta-hydroxy-2'-deoxyuridine
    基于异手性DNA中L-核苷酸残基的构象特征,设计了在大约180度具有受限糖苷构象的碳环嘧啶核苷类似物,并进行了合成。(+/-)-碳环6,6'-O-环-2'-脱氧尿苷的合成是通过碳环6'β-羟基-2'-脱氧尿苷的溴化和随后的分子内环化来实现的。(4-)-碳环6,6'-O-环-2'-脱氧胞苷通过4-三唑中间体由受保护的碳环6,6'-O-环-2'-脱氧尿苷合成。
  • Racemic synthesis of carbocyclic purine nucleoside analogues with restricted glycosyl conformation
    作者:Hidehito Urata、Hidetaka Miyagoshi、Takashi Yumoto、Masao Akagi
    DOI:10.1039/a901884k
    日期:——
    Carbocyclic purine nucleoside analogues which have restricted glycosyl conformation at χ ≈ 180° were designed, based on the conformational features of the L-nucleotide residue in heterochiral DNA, and synthesized. The synthesis of (±)-carbocyclic 8,6′-O-anhydro-8,6′-dihydroxy-2′-deoxyadenosine 3 was achieved by intramolecular cyclization of the 8-bromo-6′-O-tosyl-2′-deoxyadenosine derivative. (±)-Carbocyclic
    碳环嘌呤核苷类似物,其在具有受限制的构象糖χ 听,说:180°设计的基础上,构象特征大号个核苷酸残基在异向DNA,和合成。的合成(±) -碳环8,6'- Ô -anhydro-8,6'二羟基-2'-脱氧腺苷3通过的分子内环化实现8-溴-6'- ö甲苯磺酰基-2'-脱氧腺苷衍生物。(±) -碳环8,6'- Ô -anhydro-8,6'二羟基-2'-脱氧鸟苷4从碳环2,6-二氨基嘌呤核苷衍生物合成经由碳环8-溴-6'- ø -甲磺酰基-2'-脱氧鸟苷衍生物。
  • BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro
    作者:G.S. Bisacchi、S.T. Chao、C. Bachard、J.P. Daris、S. Innaimo、G.A. Jacobs、O. Kocy、P. Lapointe、A. Martel、Z. Merchant、W.A. Slusarchyk、J.E. Sundeen、M.G. Young、R. Colonno、R. Zahler
    DOI:10.1016/s0960-894x(96)00594-x
    日期:1997.1
    BMS-200475, a novel carbocyclic analog of 2'-deoxyguanosine, is a potent inhibitor of hepatitis B virus in vitro (ED(50)=3 nM) with relatively low cytotoxicity (CC50=21-120 mu M). A practical 10-step asymmetric synthesis was developed affording BMS-200475 in 18% overall chemical yield and >99% optical purity. The enantiomer of EMS-200475 as well as the adenine, thymine, and iodouracil analogs are much less active. (C) 1997, Elsevier Science Ltd.
  • Synthesis and hybridization properties of<scp>l</scp>-oligodeoxynucleotide analogues fixed in a low anti glycosyl conformation
    作者:Hidehito Urata、Hidetaka Miyagoshi、Tetsuya Kumashiro、Takashi Yumoto、Keiji Mori、Keiko Shoji、Keigo Gohda、Masao Akagi
    DOI:10.1039/b312276j
    日期:——
    We have synthesized L-type enantiomers (cU and cA) of nucleoside analogues, whose glycosyl bonds are fixed in a low anti conformation (ap glycosyl conformation, χ ≈ 180°), and incorporated them into oligonucleotides to evaluate the hybridization ability with natural DNA and RNA sequences. Although the incorporation of the modified nucleosides into oligonucleotides decreased the hybridization ability with unmodified complementary DNA sequences, the fully-substituted 12mers (cU12 and cA12) still retained the hybridization ability with the complementary unmodified DNA 12mers, regardless of their unnatural L-chirality. In contrast, cU12 and cA12 showed different hybridization behavior with complementary unmodified RNA 12mers. cU12 forms a more stable duplex with rA12 than the corresponding natural 12mer (dT12), whereas cA12 cannot hybridize with rU12. Based on the model structure of cU12–rA12, we discuss these experimental results.
    我们合成了核苷类似物的 L 型对映体(cU 和 cA),其糖基键以低反构象(ap 糖基构象,χ ≈ 180°)固定,并将其加入寡核苷酸中,评估其与天然 DNA 和 RNA 序列的杂交能力。虽然将修饰的核苷掺入寡核苷酸中会降低与未修饰的互补 DNA 序列的杂交能力,但完全取代的 12 聚体(cU12 和 cA12)仍能保持与未修饰的互补 DNA 12 聚体的杂交能力,而不管它们的非天然 L 手性如何。cU12 与 rA12 形成的双链比相应的天然 12 聚体(dT12)更稳定,而 cA12 则不能与 rU12 杂交。基于 cU12-rA12 的模型结构,我们对这些实验结果进行了讨论。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐